Clinical Trials on CD20-positive B-cell Non-Hodgkin's Lymphoma
Total 6375 results
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.RecruitingStudy of IMM0306 in Patients With Relapsed or Refractory CD20-positive B-cell Non-Hodgkin's LymphomaCD20-positive B-cell Non-Hodgkin's LymphomaChina
-
Shanghai Pharmaceuticals Holding Co., LtdCompletedCD20 Positive B Cell Non-Hodgkin's LymphomaChina
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedCD20-positive B-cell Non-Hodgkin LymphomaUnited States, France
-
National Cancer Institute (NCI)CompletedRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | CD20 PositiveUnited States
-
The First Affiliated Hospital of Soochow UniversityShanghai Unicar-Therapy Bio-medicine Technology Co.,LtdUnknownRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma | CAR - T CD19/CD20/CD22/CD30China
-
Fondazione Italiana Linfomi ONLUSTerminatedCD20 Positive Diffuse Large B-cell Lymphoma | Elderly Unfit PatientsItaly
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Novartis PharmaceuticalsCompletedMantle Cell Lymphoma | Gray Zone Lymphoma | Hodgkin's Disease | CD20+, B-cell Lymphomas | Non-Mantle Cell Low Grade B Cell Lymphomas (SLL/CLL) | Transformed Lymphoma/DLBCL/PMBCLUnited States
-
Han weidongRecruitingRelapsed and Refractory B-cell Non-Hodgkin's Lymphoma | Decitabine-primed Tandem CD19/CD20 CAR T CellsChina
-
Beijing Mabworks Biotech Co., Ltd.CompletedCD20-positive B Cell Non-Hodgkin LymphomaChina
-
Zhejiang Teruisi Pharmaceutical Inc.RecruitingCD20-positive B-cell Non-Hodgkin LymphomaChina
-
Estrella Biopharma, Inc.Eureka Therapeutics Inc.Not yet recruitingLymphoma | Lymphoma, Non-Hodgkin | Non-Hodgkin's Lymphoma | Non-Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | High-grade B-cell Lymphoma | CNS Lymphoma | Lymphomas Non-Hodgkin's B-Cell | Relapsed Non-Hodgkin Lymphoma | Lymphoma, Non-Hodgkins | Large B-Cell Lymphoma and other conditions
-
Abramson Cancer Center of the University of PennsylvaniaCompletedCD30-Positive Diffuse Large B-Cell Lymphoma | CD30 Positive Primary Mediastinal Large B-cell Lymphoma | CD30-Positive Gray Zone LymphomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedDiffuse Large B-Cell Lymphoma | Burkitt Lymphoma | Mantle Cell Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Indolent Non-Hodgkin Lymphoma | CD20-Positive Neoplastic Cells Present | Refractory Mature B-Cell Non-Hodgkin LymphomaUnited States
-
AbbVieGenentech, Inc.Active, not recruitingNon-Hodgkin's Lymphoma | Hematological Malignancies | Chronic Lymphoid Leukemia | CD20-Positive Lymphoid MalignanciesUnited States, Australia
-
Medical College of WisconsinMidwest Athletes Against Childhood CancerNot yet recruitingLymphoma | Leukemia | Hodgkin Disease | CD30-Positive Diffuse Large B-Cell Lymphoma | CD30+ Anaplastic Large Cell Lymphoma | CD30+ Pleomorphic Large T-Cell Cutaneous Lymphoma | CD30+ Immunoblastic Large T-Cell Cutaneous LymphomaUnited States
-
Northwestern UniversityBristol-Myers Squibb; National Cancer Institute (NCI)SuspendedB-Cell Non-Hodgkin Lymphoma | Primary Mediastinal (Thymic) Large B-Cell Lymphoma | CD20 Positive | Aggressive Non-Hodgkin Lymphoma | Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma | Diffuse Large B-Cell Lymphoma Unclassifiable | Intravascular Large B-Cell Lymphoma | T-Cell/Histiocyte-Rich...United States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...Not yet recruitingHodgkin Lymphoma | Non-Hodgkin Lymphoma | Peripheral T-cell Lymphoma | Anaplastic Large Cell Lymphoma, ALK-Positive | Anaplastic Large Cell Lymphoma, ALK-negative | CD30-Positive Diffuse Large B-Cell Lymphoma | Anaplastic Large Cell Lymphoma, T Cell and Null Cell TypeUnited States
-
Lymphoma Study AssociationTerminatedCD20-Positive Large B-Cell LymphomaFrance
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.CompletedIndolent B-Cell Non-Hodgkin's LymphomasChina
-
Lymphoma Study AssociationAmgenCompletedUntreated CD20-positive Large B-cell LymphomaFrance
-
The Lymphoma Academic Research OrganisationHoffmann-La RocheTerminatedDiffuse Large B Cell Lymphoma CD20 PositiveFrance, Belgium
-
Caribou Biosciences, Inc.RecruitingLymphoma | Lymphoma, Non-Hodgkin | B Cell Lymphoma | Non Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma | B Cell Non-Hodgkin's LymphomaUnited States, Australia, Israel
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Recurrent Diffuse Large B-Cell Lymphoma | CD20 Positive | T-Cell Non-Hodgkin LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | High Grade B-Cell Non-Hodgkin's Lymphoma | Intermediate Grade B-Cell Non-Hodgkin's LymphomaUnited States
-
Precision BioSciences, Inc.CompletedLymphoma, Non-Hodgkin | Chronic Lymphocytic Leukemia | B-cell Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | B-cell Non Hodgkin Lymphoma | Leukemia, Lymphocytic, Chronic | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin's Lymphoma Refractory | Chronic Lymphoid Leukemia in RelapseUnited States
-
Genentech, Inc.CompletedChronic Lymphocytic Leukemia | Non-Hodgkins LymphomaUnited States, France, Canada, Netherlands
-
University of GiessenCompletedMarginal Zone Lymphomas | Non-Hodgkin Lymphomas | Follicular Lymphomas | Immunocytomas | Lymphocytic LymphomasGermany
-
Sidney Kimmel Cancer Center at Thomas Jefferson...GlaxoSmithKline; NovartisTerminatedChronic Lymphocytic Leukemia | B-Cell Non-Hodgkin's LymphomaUnited States
-
Guangzhou Excelmab Inc.RecruitingSafety and Efficacy of EX103 in Subjects With Relapsed/Refractory CD20-Positive Non-Hodgkin LymphomaCD20-positive Non-Hodgkin LymphomaChina
-
Conjupro Biotherapeutics, Inc.SuspendedCD20 Positive Non Hodgkin LymphomaUnited States
-
Seoul National University HospitalGyeongsang National University Hospital; Hallym University Medical Center; Kyunghee...TerminatedCD20-positive Non-Hodgkin LymphomaKorea, Republic of
-
University of PennsylvaniaCompletedNon-Hodgkins Lymphoma (NHL) Patients, With CD19+B Cell LymphomasUnited States
-
Nanjing Sanhome Pharmaceutical, Co., Ltd.UnknownChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | B-Cell Non-Hodgkin Lymphomas(NHL)China
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...RecruitingRefractory B-Cell Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma | Relapsed Adult ALL | Relapsed CLL | Refractory B-Cell Small Lymphocytic LymphomaUnited States
-
Fujian Medical UniversityRecruitingRelapsed or Refractory DLBCL Patients With Either CD19 or CD20 PositiveChina
-
Gilead SciencesCompletedMantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Indolent Non-Hodgkin's LymphomaUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisChildren's Oncology GroupUnknownB-cell Non Hodgkin Lymphoma | Mature B-cell Leukemia Burkitt-typeBelgium, France, United Kingdom, Netherlands, Canada, Hungary, Italy, Poland, Spain, China
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma, Chronic Lymphocytic LeukemiaUnited States
-
Oncology Specialists, S.C.University of Illinois at ChicagoTerminatedNon-Hodgkin LymphomasUnited States
-
Heidelberg UniversityLudwig-Maximilians - University of Munich; Universitätsmedizin Mannheim; Diakonie... and other collaboratorsUnknownB-Cell Chronic Lymphocytic Leukemia | B-Cell Non-Hodgkin's Lymphoma | Immunocytoma/Morbus Waldenström
-
SCRI Development Innovations, LLCGenentech, Inc.; AmgenCompletedNon-Hodgkins LymphomaUnited States
-
Eureka Therapeutics Inc.Duke University; Duke Clinical Research InstituteTerminatedLymphomas Non-Hodgkin's B-CellUnited States
-
University of ChicagoActive, not recruitingCLL | B-cell Non Hodgkin LymphomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | CD20 PositiveUnited States
-
Nationwide Children's HospitalNot yet recruitingAcute Lymphoblastic Leukemia, in Relapse | B Cell Leukemia | B-cell Non Hodgkin Lymphoma | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin's Lymphoma Refractory | Acute Lymphoblastic Leukemia With Failed RemissionUnited States
-
Institute of Hematology & Blood Diseases HospitalCancer Institute and Hospital, Chinese Academy of Medical Sciences; Beijing...UnknownNon-Hodgkin's Lymphoma | Peripheral T Cell Lymphoma | Relapsed or Refractory B Cell Non-Hodgkin's Lymphoma | Chronic Lymphoblastic LeukemiaChina
-
Peking UniversityPeking University Cancer Hospital & InstituteRecruitingB Cell Non-Hodgkin's LymphomaChina
-
Peking UniversityUnknownB-cell Non-Hodgkin's Lymphoma
-
The Lymphoma Academic Research OrganisationCompletedNon Previously Treated CD20+ Diffuse Large B-cell LymphomaBelgium, France
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.Not yet recruitingB-cell Non-Hodgkin's Lymphoma